NCM

NEXTBio Capital Management Portfolio holdings

AUM $170M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$170M
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
23
New
Increased
Reduced
Closed

Top Buys

1
+$18.8M
2
+$18.6M
3
+$12.7M
4
VSTM icon
Verastem
VSTM
+$11.7M
5
ZBIO
Zenas BioPharma
ZBIO
+$10.6M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TERN icon
1
Terns Pharmaceuticals
TERN
$6.08B
$22.3M 13.06%
+551,190
PTGX icon
2
Protagonist Therapeutics
PTGX
$6.68B
$20.1M 11.76%
+229,619
VOR icon
3
Vor Biopharma
VOR
$775M
$13.1M 7.67%
+999,967
ZBIO
4
Zenas BioPharma
ZBIO
$1.33B
$11.7M 6.86%
+321,983
STTK icon
5
Shattuck Labs
STTK
$512M
$11.5M 6.74%
+3,149,907
VSTM icon
6
Verastem
VSTM
$539M
$10.1M 5.92%
+1,307,330
PVLA
7
Palvella Therapeutics
PVLA
$1.85B
$8.65M 5.08%
+82,686
XENE icon
8
Xenon Pharmaceuticals
XENE
$5.66B
$8.23M 4.83%
+183,704
RYTM icon
9
Rhythm Pharmaceuticals
RYTM
$5.96B
$7.23M 4.24%
+67,586
GPCR icon
10
Structure Therapeutics
GPCR
$3.77B
$6.57M 3.85%
+94,443
IVA
11
Inventiva
IVA
$1.14B
$6.04M 3.54%
+1,298,701
CMPX icon
12
Compass Therapeutics
CMPX
$980M
$5.98M 3.51%
+1,114,005
CMPS
13
Compass Pathways
CMPS
$741M
$5.19M 3.05%
+752,631
ORIC icon
14
Oric Pharmaceuticals
ORIC
$1.18B
$5.04M 2.95%
+615,720
CBIO
15
Crescent Biopharma
CBIO
$594M
$4.42M 2.59%
+372,856
PCVX icon
16
Vaxcyte
PCVX
$9.03B
$4.41M 2.58%
+95,485
EVMN
17
Evommune Inc
EVMN
$959M
$3.91M 2.29%
+228,286
COGT icon
18
Cogent Biosciences
COGT
$5.92B
$3.4M 2%
+95,819
IRON icon
19
Disc Medicine
IRON
$2.69B
$3.4M 1.99%
+42,778
OCS icon
20
Oculis Holding
OCS
$1.6B
$2.99M 1.75%
+149,750
ZLAB icon
21
Zai Lab
ZLAB
$2.47B
$2.88M 1.69%
+163,362
KALV icon
22
KalVista Pharmaceuticals
KALV
$1.04B
$2.13M 1.25%
+131,796
ACET icon
23
Adicet Bio
ACET
$67.2M
$1.33M 0.78%
+157,827